SMARCA5 and breast carcinoma: Namely, the interaction of circSMARCA5 with SMARCA5 could suppress the expression of SMARCA5, which is vital for DNA damage repair, and altered DNA damage repair modulated the sensitivity of breast cancer cells to cytotoxic drugs [142, 170].